Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00127712 · ClinicalTrials.gov registry record · Phase 4
Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
NCT00127712 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 130 participants.
The verdict
NCT00127712, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
Study Summary
The investigators hypothesize that the medication amiodarone decreases the incidence of atrial fibrillation (AF) following non-cardiac open-chest surgery. Their specific aims are to: * Determine the effectiveness of amiodarone for the prevention of AF following non-cardiac open-chest surgery; * Determine the influence of the prevention of AF following non-cardiac thoracic surgery on post-surgical duration of stay in the Intensive Care Unit (ICU); post-surgical duration of stay in a hospital unit that employs cardiac monitoring; and duration of post-surgical hospital stay; and * Determine the safety of amiodarone for the prevention of AF following non-cardiac open-chest surgery.
Interventions
- DRUG Amiodarone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2004-09 |
| Est. Completion | 2008-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00127712
The ClinicalTrials.gov registry entry for NCT00127712 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amiodarone is the first listed.
NCT00127712 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00127712 about?
NCT00127712 is a clinical study titled "Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery". The investigators hypothesize that the medication amiodarone decreases the incidence of atrial fibrillation (AF) following non-cardiac open-chest surgery. Their specific aims are to: * Determine the effectiveness of amiodarone for the prevention of AF following non-cardiac open-chest surgery; * Det...
What is the current status of trial NCT00127712?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2004-09. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00127712?
The interventions under investigation include: Amiodarone (DRUG).
Who is sponsoring clinical trial NCT00127712?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.